Industry Trend

Site Sections

Menu








© 2023. All Rights reserved.

Overview for HIKMA PHARMACEUTICALS

All Data per March 3, 2023

Industry:

Drug Manufacturers—Specialty & Generic

Last Close:

17.58 GBP

Expected Dividend:

2.39 %

Payoffs per Year:

2.0
Business Summary
Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment develops, manufactures, and sells generic injectable products primarily for use in hospitals. The Generics segment develops, manufactures, and sells oral and other non-injectable generic products for the retail market. The Branded segment develops, manufactures, markets, and sells branded generics and in-licensed products to retail and hospital markets. The company offers its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, anesthetic, sedative, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.

Competitors View

Ordering

MERCK KGAA

GER		 1.06 1.75%
1.13%		 4.16% 1.93% 1.0 6.9
-9.48%		 23.3 11.04% 47.04 1.0

SHIONOGI

JPN		 0.93 1.58%
1.99%		 4.3% 1.75% 1.0 4.25
-16.73%		 22.76 -6.97% 84.7 2.0

HIKMA PHARMACEUTICALS

GBR
 1.11 1.38%
2.39%		 5.42% 1.61% 1.0 0.7
-50.72%		 20.04 6.65% 56.11 3.0

SUMITOMO DAINIPPON PHARMA

JPN		 0.88 1.22%
3.33%		 1.09% 1.17% 1.0 0.22
-62.09%		 16.98 9.14% 44.38 4.0

EISAI

JPN		 1.12 2.76%
0.0%		 0.0% 2.53% 1.0 0.95
-23.18%		 44.21 -30.92% 64.51 5.0

ZOETIS

USA		 1.0 0.67%
0.76%		 8.43% 0.9% 1.0 -inf
0.0%		 17.13 9.35% 32.68 6.0

PERRIGO COMPANY

USA		 0.95 0.65%
2.68%		 6.42% 0.79% 1.0 -0.41
-76.82%		 32.42 -66.67% 49.41 7.0

DERMAPHARM

GER		 0.88 1.16%
5.46%		 4.02% 1.27% -0.5 -inf
0.0%		 29.76 12.15% 35.35 8.0

TAKEDA PHARMACEUTICAL

JPN		 1.06 3.88%
0.0%		 0.0% 3.55% -1.0 -0.23
-50.99%		 37.82 22.16% 40.06 9.0

KANGMEI PHARMACEUTICAL

CHN		 0.98 1.12%
nan%		 0.0% 1.03% 0.0 -0.17
-88.01%		 227.16 505.79% 61.83 nan

Information for HIKMA PHARMACEUTICALS

Yield Triangle

Dividend & Close

Close Dividend Return (%)
Year
2012 7.61 0.08 1.05
2013 12.01 0.11 0.92
2014 19.79 0.12 0.61
2015 23.01 0.17 0.74
2016 18.93 0.23 1.22
2017 11.34 0.30 2.65
2018 17.16 0.25 1.46
2019 19.91 0.34 1.71
2020 25.18 0.36 1.43
2021 22.19 0.38 1.71
2023 17.58 0.42 2.39

Fundamentals

Chart